Traws Pharma, Inc.
Institutional Ownership & Holdings Analysis
About
traws-pharma is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.
Top Institutional Holders
# | Institution | Value |
---|---|---|
1 | ORBIMED ADVISORS LLC(2025-03-31) | $1.4M |
2 | PERCEPTIVE ADVISORS LLC(2025-03-31) | $970.1K |
3 | ADAGE CAPITAL PARTNERS GP, L.L.C.(2025-03-31) | $759.0K |
4 | Vestal Point Capital, LP(2025-03-31) | $402.5K |
5 | Alyeska Investment Group, L.P.(2025-03-31) | $121.0K |
6 | RENAISSANCE TECHNOLOGIES LLC(2024-12-31) | $89.3K |
7 | GEODE CAPITAL MANAGEMENT, LLC(2025-03-31) | $76.8K |
8 | BOOTHBAY FUND MANAGEMENT, LLC(2025-03-31) | $76.6K |
9 | Ikarian Capital, LLC(2025-03-31) | $65.5K |
10 | UBS Group AG(2025-03-31) | $32.9K |
11 | VANGUARD GROUP INC(2025-03-31) | $30.3K |
12 | MILLENNIUM MANAGEMENT LLC(2025-03-31) | $23.2K |
13 | BlackRock, Inc.(2025-03-31) | $22.9K |
14 | GROUP ONE TRADING LLC(2024-12-31) | $10.3K |
15 | Tower Research Capital LLC (TRC)(2025-03-31) | $7.5K |
16 | MORGAN STANLEY(2025-03-31) | $1.7K |
17 | SBI Securities Co., Ltd.(2025-03-31) | $1.2K |
18 | Vermillion & White Wealth Management Group, LLC(2025-03-31) | $221 |
19 | BANK OF AMERICA CORP /DE/(2025-03-31) | $175 |
20 | Banque Transatlantique SA(2025-03-31) | $38 |
As of 2025-03-31
Value:$1.4M
As of 2025-03-31
Value:$970.1K
As of 2025-03-31
Value:$759.0K
As of 2025-03-31
Value:$402.5K
As of 2025-03-31
Value:$121.0K
As of 2024-12-31
Value:$89.3K
As of 2025-03-31
Value:$76.8K
As of 2025-03-31
Value:$76.6K
As of 2025-03-31
Value:$65.5K
#10UBS Group AG
As of 2025-03-31
Value:$32.9K
As of 2025-03-31
Value:$30.3K
As of 2025-03-31
Value:$23.2K
As of 2025-03-31
Value:$22.9K
As of 2024-12-31
Value:$10.3K
As of 2025-03-31
Value:$7.5K
As of 2025-03-31
Value:$1.7K
As of 2025-03-31
Value:$1.2K
As of 2025-03-31
Value:$221
As of 2025-03-31
Value:$175
As of 2025-03-31
Value:$38
Total Institutional Holders:23
Top 10 Holders Own:97.6%